Updated questions and answers on the Windsor Framework

We have updated our webpage relating to the impact of the Windsor Framework on the regulation of human medicines.

The page is based on questions the HPRA has received from companies and includes updated information on:

• Joint labels between IE/UK
• Medicines moving from Northern Ireland to the Republic of Ireland
• The expiry of Brexit Derogations approved in Ireland

Further questions on this topic can be sent to brexit@hpra.ie. We will continue to update the page as necessary.